Items where authors include "Corinaldesi, C"

Article

Ross, RL, Corinaldesi, C, Migneco, G et al. (9 more authors) (2021) Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma. Annals of the Rheumatic Diseases (ARD). ISSN 0003-4967

Wasson, CW, Ross, RL, Wells, R et al. (4 more authors) (2020) Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts. Arthritis Research and Therapy, 22. 286. ISSN 1478-6354

Crescioli, C, Corinaldesi, C, Riccieri, V et al. (7 more authors) (2018) Association of circulating CXCL10 and CXCL11 with systemic sclerosis. Annals of the Rheumatic Diseases, 77 (12). pp. 1845-1846. ISSN 0003-4967

Gillespie, J, Ross, RL, Corinaldesi, C et al. (7 more authors) (2018) Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2. Arthritis & Rheumatology, 70 (6). pp. 932-942. ISSN 2326-5191

Conference or Workshop Item

Ross, R, Corinaldesi, C, Migneco, G et al. (5 more authors) (2019) BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Proceedings Paper

Corinaldesi, C, El-Sherbiny, YM, Migneco, G et al. (4 more authors) (2018) CBS004, a Novel Monoclonal Antibody Against Bdca-2 Inhibits TLR-Induced Activation of Human pDC in Vitro and In Vivo. a Novel Therapeutic Target for Systemic Sclerosis. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL. Wiley .